The Effect of Fluorocarbon Emulsion on Placental Insufficiency

  • N. S. Faithfull
  • H. W. Marshall
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 248)


Oxygen-carrying plasma substitutes based on emulsified perfluorocarbons (PFCs) have undergone extensive experimental and clinical evaluation over the last 10 years. Though they were originally introduced as “artificial blood”, it is clear that their use will probably be largely in more specialised areas such as improvement of microcirculatory oxygenation in, for instance, the treatment of myocardial and cerebral ischaemia (Böse et al. 1986; Faithfull et al. 1986) or improvement of oxygenation, and hence radiosensitivity, of malignant tumours (Teicher and Rose 1984).


Uterine Horn Foetal Weight Placental Insufficiency Isolate Lung Perfusion Fluorocarbon Emulsion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bose, B., Osterholra, J.L., Payne, J.B. and Chambers, K., 1986. Preservation of neuronal function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion. Neurosurgery 18:270.PubMedCrossRefGoogle Scholar
  2. Colman, R.W., Chang, L.K., Mukherji, B. and Sloviter, H.A., 1980. Effects of a perfluoro erythrocyte substitute on platelets in vitro and in vivo. J. Lab. Clin. Med. 95:553.PubMedGoogle Scholar
  3. Clark, L.C., Kaplan, S. and Becattini, F., 1970. The physiology of synthetic blood. J. Thorac. Cardiovasc. Surg. 60: 757.PubMedGoogle Scholar
  4. Erdmann, W., 1982. 02 Diffusion coefficients. In:Oxygen Carrying Colloidal Blood Substitutes, Eds. Frey R, Beisbarth H, Stossek K. W Zuckschwerdt Verlag, Munich. p 143.Google Scholar
  5. Faithfull, N.S., Fennema, M., Erdmann, W., Lapin, R., Smith, A.R., van Alphen, W., Essed, C.E. and Trouwborst, A., 1985. Tissue oxygenation by fluorocarbons. Adv. Exp. Med. Biol. 180:569.Google Scholar
  6. Faithfull, N.S., Erdmann, W., Fennema, M. and Kok, A., 1986. The effects of haemodilution with fluorocarbons or dextran on oxygen tensions in the acutely ischaemic myocardium. Brit. J. Anaesth. 58:1031.PubMedCrossRefGoogle Scholar
  7. Faithfull, N.S., King, C.E. and Cain, S.M., 1987. Peripheral vascular responses to fluorocarbon administration. Microvasc. Res. 33:183.PubMedCrossRefGoogle Scholar
  8. Faithfull, N.S. and Cain, S.M., 1988. Critical oxygen delivery following haemodilution with dextran or Fluosol-DA. J. Crit. Care 3:14.CrossRefGoogle Scholar
  9. Faithfull, N.S. and Cain, S.M., 1988. Cardiorespiratory consequences of fluorocarbon rections in dogs. Biomat. Art. Cells and Art. Organs 16:463.Google Scholar
  10. Moll, W., 1973. Placental Function and oxygenation in the foetus. Adv. Exp. Med. Biol. 37:1017.PubMedGoogle Scholar
  11. Naito, R., Fujita, Y. and Suyama, T., 1978. Studies on teratogenicity of Fluosol-DA in rats. In: Proceedings of the Symposiun on Research on Perfluorochemicals in Medicine and Biology. V. Novakova and L.-O. Plantin, eds. GOTAB, Stockholm.Google Scholar
  12. O’Brodovich, H., Belbeck, L., Andrew, M. and Coates, G., 1985. Fluosol-DA causes pulmonary hypertension and increased lymph lung flow in un anesthetised sheep. Clin. Invest. Med. 8:15.PubMedGoogle Scholar
  13. Rude, R.E., Bush, L.R. and Tilton, G.D., 1984. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and Energetics. Am. J. Cardiol. 54:80.CrossRefGoogle Scholar
  14. Saeed, M., Hartmann, A. and Bing, R., 1987. Inhibition of vasoactive agents by perfluorochemical emulsion. Life Sci. 40:1971.PubMedCrossRefGoogle Scholar
  15. Shakir, K.M.M., and Williams, T.J., 1982. Inhibition of Phospholipase A2 acticity by Fluosol, and artificial blood substitute. Prostoglandins 23:919.CrossRefGoogle Scholar
  16. Teicher, B.A. and Rose, C. M, 1984. Oxygen-carrying perfluorochemical emulsion as an adjuvent to radiation therapy in mice. Cancer Res. 44:4285.PubMedGoogle Scholar
  17. Tremper, K.K., Vercellotti, G.M. and Hammerschmidt, D.E., 1984. Hemodynamic profile of adverse clinical reactions to Fluosol-DA 20%. Crit. Care Med. 12:428.CrossRefGoogle Scholar
  18. Vercellotti, G.M., Hammerschmidt, D.E., Craddock, P.R., and Jacob, H.S., 1982. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis. Blood 59:1299.PubMedGoogle Scholar
  19. Vileisis, R.A., 1985. Effect of Maternal Oxygen Inhalation on the fetus with growth retardation. Ped. Res. 19:324.CrossRefGoogle Scholar
  20. Wigglesworth, J.S., 1964. Experimental growth retardation in the foetal rat. Pathol. Bacteriol. 88:1.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • N. S. Faithfull
    • 1
  • H. W. Marshall
    • 1
  1. 1.Department of AnaesthesiaUniversity of Manchester and Northwest Injury Research GroupManchesterUK

Personalised recommendations